Works by Kang, Sun W.


Results: 4
    1
    3
    4

    Efficacy, safety and albuminuria-reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12-week, double-blind randomized study (the GUARD Study).

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 590, doi. 10.1111/dom.12863
    By:
    • Yoon, Sun A.;
    • Han, Byoung G.;
    • Kim, Sung G.;
    • Han, Sang Y.;
    • Jo, Young I.;
    • Jeong, Kyung H.;
    • Oh, Kook H.;
    • Park, Hyeong C.;
    • Park, Sun H.;
    • Kang, Shin W.;
    • Na, Ki R.;
    • Kang, Sun W.;
    • Kim, Nam H.;
    • Jang, Young H.;
    • Shin, Seong H.;
    • Cha, Dae R.
    Publication type:
    Article